• This fund invests primarily in equity securities of companies throughout the world which are involved in the design, manufacture, or sale of products and services used for or in connection with health care, medicine or
biotechnology.
• The fund is subject to equities risk, risk to capital and income, foreign currency risk, valuation risk and stock/issuer concentration risk. The fund may invest in a single sector and may have greater exposures to the market, liquidity, tax, legal, regulatory, and economic risks of those sectors.
• The fund’s net derivative exposure may be up to 50% of its NAV, the use of derivatives may involve liquidity risk,
counterparty credit risk, volatility risk, valuations risks and over-the-counter transaction risk, at times. Exposure to financial derivative instruments and its leverage element may lead to a high risk of significant loss by the fund.
• Investors may suffer substantial loss of their investments in the fund. Investor should not invest in the fund solely based on the information provided in this document and should read the offering documents, including Product Key Facts (including the risk factors) for details.